In this prospective cohort study, participants with social risk factors at the time of SARS-CoV-2 infection had a higher risk ...

In this randomized controlled trial, rituximab was not superior to standard treatment in inducing remission in patients with ...

The addition of ramucirumab to irinotecan in patients with ramucirumab-refractory advanced or recurrent gastric or ...

D concentration were nonlinearly associated with decreased all-cause, cardiovascular disease mortality, and cancer mortality, ...